Annual ROA
-15.37%
-101.54%-117.84%
December 31, 2023
Summary
- As of February 7, 2025, TXMD annual return on assets is -15.37%, with the most recent change of -101.54% (-117.84%) on December 31, 2023.
- During the last 3 years, TXMD annual ROA has risen by +66.63% (+81.26%).
- TXMD annual ROA is now -117.84% below its all-time high of 86.17%, reached on December 31, 2022.
Performance
TXMD ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-7.69%
+5.56%+41.96%
September 30, 2024
Summary
- As of February 7, 2025, TXMD quarterly return on assets is -7.69%, with the most recent change of +5.56% (+41.96%) on September 30, 2024.
- Over the past year, TXMD quarterly ROA has increased by +9.58% (+55.47%).
- TXMD quarterly ROA is now -105.51% below its all-time high of 139.66%, reached on March 31, 2023.
Performance
TXMD Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
TXMD ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -117.8% | +55.5% |
| 3 y3 years | +81.3% | -105.5% |
| 5 y5 years | +79.4% | -105.5% |
TXMD ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -117.8% | +84.3% | -105.5% | +91.9% |
| 5 y | 5-year | -117.8% | +84.3% | -105.5% | +91.9% |
| alltime | all time | -117.8% | +98.4% | -105.5% | +99.8% |
TherapeuticsMD ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -7.69%(-42.0%) |
| Jun 2024 | - | -13.25%(-10.9%) |
| Mar 2024 | - | -14.87%(-13.9%) |
| Dec 2023 | -15.37%(-117.8%) | -17.27%(-119.6%) |
| Sep 2023 | - | 87.99%(+99.3%) |
| Jun 2023 | - | 44.15%(-68.4%) |
| Mar 2023 | - | 139.66%(+67.9%) |
| Dec 2022 | 86.17%(-187.7%) | 83.16%(-1620.3%) |
| Sep 2022 | - | -5.47%(-64.9%) |
| Jun 2022 | - | -15.60%(-83.5%) |
| Mar 2022 | - | -94.58%(+10.9%) |
| Dec 2021 | -98.22%(+19.8%) | -85.30%(+1.3%) |
| Sep 2021 | - | -84.22%(+9.0%) |
| Jun 2021 | - | -77.26%(-0.2%) |
| Mar 2021 | - | -77.42%(-7.3%) |
| Dec 2020 | -82.00%(+11.2%) | -83.49%(+2.1%) |
| Sep 2020 | - | -81.75%(+6.3%) |
| Jun 2020 | - | -76.91%(-3.6%) |
| Mar 2020 | - | -79.75%(+4.7%) |
| Dec 2019 | -73.71%(-1.3%) | -76.16%(+3.4%) |
| Sep 2019 | - | -73.68%(-8.9%) |
| Jun 2019 | - | -80.90%(+1.4%) |
| Mar 2019 | - | -79.81%(+6.7%) |
| Dec 2018 | -74.67%(+38.7%) | -74.77%(+8.9%) |
| Sep 2018 | - | -68.64%(+3.3%) |
| Jun 2018 | - | -66.43%(+9.0%) |
| Mar 2018 | - | -60.93%(+7.3%) |
| Dec 2017 | -53.85%(-35.2%) | -56.78%(+0.5%) |
| Sep 2017 | - | -56.52%(-9.6%) |
| Jun 2017 | - | -62.53%(+10.4%) |
| Mar 2017 | - | -56.65%(-6.1%) |
| Dec 2016 | -83.14%(-35.1%) | -60.35%(-1.1%) |
| Sep 2016 | - | -61.02%(-5.8%) |
| Jun 2016 | - | -64.80%(-18.9%) |
| Mar 2016 | - | -79.94%(-25.1%) |
| Dec 2015 | -128.12%(+43.1%) | -106.77%(+1.6%) |
| Sep 2015 | - | -105.05%(-9.8%) |
| Jun 2015 | - | -116.42%(+17.0%) |
| Mar 2015 | - | -99.54%(+7.8%) |
| Dec 2014 | -89.54%(+7.0%) | -92.30%(+20.9%) |
| Sep 2014 | - | -76.37%(+14.8%) |
| Jun 2014 | - | -66.53%(+15.5%) |
| Mar 2014 | - | -57.58%(-9.4%) |
| Dec 2013 | -83.66%(-91.2%) | -63.57%(-18.6%) |
| Sep 2013 | - | -78.06%(-29.1%) |
| Jun 2013 | - | -110.09%(-53.2%) |
| Mar 2013 | - | -235.06%(-76.9%) |
| Dec 2012 | -953.76%(-2.7%) | -1018.28%(-40.8%) |
| Sep 2012 | - | -1720.72%(-25.7%) |
| Jun 2012 | - | -2316.19%(-46.4%) |
| Mar 2012 | - | -4323.92%(+77.4%) |
| Dec 2011 | -979.78% | -2436.71%(+49.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2011 | - | -1628.34%(+153.2%) |
| Jun 2011 | - | -643.04%(+56.8%) |
| Mar 2011 | - | -410.17%(+39.2%) |
| Dec 2010 | -280.16%(-23.4%) | -294.72%(+110.9%) |
| Sep 2010 | - | -139.74%(-38.1%) |
| Jun 2010 | - | -225.60%(-26.6%) |
| Mar 2010 | - | -307.20%(-14.1%) |
| Dec 2009 | -365.97%(+154.3%) | -357.57%(+10.5%) |
| Sep 2009 | - | -323.59%(+75.7%) |
| Jun 2009 | - | -184.13%(-34.5%) |
| Mar 2009 | - | -281.13%(+65.5%) |
| Dec 2008 | -143.89%(-1096.5%) | -169.85%(+151.0%) |
| Sep 2008 | - | -67.68%(+136.6%) |
| Jun 2008 | - | -28.60%(-566.6%) |
| Mar 2008 | - | 6.13%(-40.7%) |
| Dec 2007 | 14.44%(+95.1%) | 10.34%(+245.8%) |
| Sep 2007 | - | 2.99%(-53.3%) |
| Jun 2007 | - | 6.40%(-13.4%) |
| Mar 2007 | - | 7.39%(-3.8%) |
| Dec 2006 | 7.40%(-66.9%) | 7.68%(-69.3%) |
| Sep 2006 | - | 25.01%(+2.1%) |
| Jun 2006 | - | 24.50%(+14.4%) |
| Mar 2006 | - | 21.41%(-11.7%) |
| Dec 2005 | 22.34%(+56.1%) | 24.26%(+1.6%) |
| Sep 2005 | - | 23.87%(+15.6%) |
| Jun 2005 | - | 20.64%(-11.9%) |
| Mar 2005 | - | 23.44%(+61.5%) |
| Dec 2004 | 14.31%(+25.5%) | 14.51%(+57.0%) |
| Sep 2004 | - | 9.24%(+11.5%) |
| Jun 2004 | - | 8.29%(+22.3%) |
| Mar 2004 | - | 6.78%(-40.4%) |
| Dec 2003 | 11.40%(-16.5%) | 11.37%(-11.9%) |
| Sep 2003 | - | 12.90%(+17.6%) |
| Jun 2003 | - | 10.97%(-7.7%) |
| Mar 2003 | - | 11.88%(-14.6%) |
| Dec 2002 | 13.66%(+46.9%) | 13.91%(+143.2%) |
| Sep 2002 | - | 5.72%(+36.5%) |
| Jun 2002 | - | 4.19%(-34.6%) |
| Mar 2002 | - | 6.41%(-28.5%) |
| Dec 2001 | 9.30%(+65.5%) | 8.97%(+11.8%) |
| Sep 2001 | - | 8.02%(-35.6%) |
| Jun 2001 | - | 12.45%(+20.5%) |
| Mar 2001 | - | 10.33%(+78.1%) |
| Dec 2000 | 5.62%(+127.5%) | 5.80%(-50.3%) |
| Sep 2000 | - | 11.66%(+64.5%) |
| Jun 2000 | - | 7.09%(+17.0%) |
| Mar 2000 | - | 6.06%(+143.4%) |
| Dec 1999 | 2.47%(-180.5%) | 2.49% |
| Dec 1998 | -3.07%(+22.8%) | - |
| Dec 1997 | -2.50%(-117.3%) | - |
| Dec 1996 | 14.46%(+114.5%) | - |
| Dec 1995 | 6.74%(-15.2%) | - |
| Dec 1994 | 7.95% | - |
FAQ
- What is TherapeuticsMD annual return on assets?
- What is the all time high annual ROA for TherapeuticsMD?
- What is TherapeuticsMD annual ROA year-on-year change?
- What is TherapeuticsMD quarterly return on assets?
- What is the all time high quarterly ROA for TherapeuticsMD?
- What is TherapeuticsMD quarterly ROA year-on-year change?
What is TherapeuticsMD annual return on assets?
The current annual ROA of TXMD is -15.37%
What is the all time high annual ROA for TherapeuticsMD?
TherapeuticsMD all-time high annual return on assets is 86.17%
What is TherapeuticsMD annual ROA year-on-year change?
Over the past year, TXMD annual return on assets has changed by -101.54% (-117.84%)
What is TherapeuticsMD quarterly return on assets?
The current quarterly ROA of TXMD is -7.69%
What is the all time high quarterly ROA for TherapeuticsMD?
TherapeuticsMD all-time high quarterly return on assets is 139.66%
What is TherapeuticsMD quarterly ROA year-on-year change?
Over the past year, TXMD quarterly return on assets has changed by +9.58% (+55.47%)